Kirsten Cowley

Kirsten Cowley has extensive experience in clinical operations, demonstrating a progressive career at REGENXBIO Inc. since June 2017, rising from Director Clinical Operations to the current role of Executive Director Clinical Operations. Prior roles include significant positions at GlycoMimetics, Novavax, and Contract Services - Clinical Research, among others. Kirsten's background encompasses leadership in clinical project management and operational strategies, with earlier experience at International HealthCare as Director of Operations and at Westat as Sr. Clinical Data Manager. Kirsten Cowley holds a Bachelor of Science in Biology from Shenandoah University, earned between 1992 and 1996.